Innovator IBD 50 ETF (NYSEARCA:FFTY – Get Free Report) was the target of a large growth in short interest in the month of October. As of October 30th, there was short interest totaling 34,755 shares, a growth of 382.4% from the October 15th total of 7,205 shares. Currently, 2.0% of the company’s shares are sold short. Based on an average trading volume of 36,072 shares, the short-interest ratio is currently 1.0 days.
Innovator IBD 50 ETF Trading Up 0.2%
Shares of NYSEARCA:FFTY traded up $0.07 during mid-day trading on Friday, reaching $29.09. The stock had a trading volume of 2,511 shares, compared to its average volume of 49,397. The firm has a 50 day simple moving average of $33.71 and a two-hundred day simple moving average of $37.15. Innovator IBD 50 ETF has a twelve month low of $28.62 and a twelve month high of $44.08. The firm has a market cap of $50.91 million, a PE ratio of 12.03 and a beta of 1.50.
Institutional Investors Weigh In On Innovator IBD 50 ETF
Several large investors have recently bought and sold shares of the company. Guardian Wealth Advisors LLC NC bought a new position in shares of Innovator IBD 50 ETF during the second quarter worth $507,000. Kraematon Investment Advisors Inc. acquired a new position in shares of Innovator IBD 50 ETF in the 2nd quarter valued at $1,021,000. Royal Bank of Canada increased its position in shares of Innovator IBD 50 ETF by 3,222.5% in the 1st quarter. Royal Bank of Canada now owns 18,274 shares of the company’s stock valued at $611,000 after buying an additional 17,724 shares in the last quarter. Concurrent Investment Advisors LLC increased its position in shares of Innovator IBD 50 ETF by 11.1% in the 2nd quarter. Concurrent Investment Advisors LLC now owns 63,128 shares of the company’s stock valued at $3,349,000 after buying an additional 6,321 shares in the last quarter. Finally, KFG Wealth Management LLC bought a new stake in shares of Innovator IBD 50 ETF in the 2nd quarter valued at $201,000.
Innovator IBD 50 ETF Company Profile
The Innovator IBD 50 ETF (FFTY) is an exchange-traded fund that is based on the IBD 50 index. The fund tracks an index of 50 US-listed stocks with aggressive growth characteristics. Holdings are selected based on fundamental and technical rankings FFTY was launched on Apr 9, 2015 and is managed by Innovator.
See Also
- Five stocks we like better than Innovator IBD 50 ETF
- Nu Holdings Earnings Show a Compounder Priced Like a Brazil Bet
- Game On: The Hidden Value in Take-Two’s Stock
- LightPath Technologies’ Record Backlog Highlights a Bigger Defense Opportunity
- A 10-Stock Strategy That Balances AI Growth With Cash Flow
Receive News & Ratings for Innovator IBD 50 ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovator IBD 50 ETF and related companies with MarketBeat.com's FREE daily email newsletter.
